The European landscape of listed biotech companies: 2018 review (Part 3)

[19] 2019 US Biotech Outlook - JP Morgan, January 2019
[20] Boom: 2018's biotech IPOs, Chris Morrison, Nature Reviews Drug Discovery, 28-12-2018
[21] Top 10 Global Biopharma IPOs of 2018, Alex Philippidis, Genetic Engineering and Biotechnology News, 14-01-2019

A vast majority of the company level data consolidated in this review are available on our intelligence service (subscription service for pro only). We provide small granularity data, and insights on the main items of biotech investing, for more than 150 companies listed on the main European markets. Disclaimer: we do not provide any investment recommendation on our service. This review is not aimed at supporting an investment decision on any company, any country, or any stock market mentioned in this report. See more details on

The author can be contacted via email, on Twitter @BertrandBio / @biotechradar_eu, or Linkedin.

Frontpage illustration generated on